AAM
STJ

Auxier Asset Management’s St Jude Medical STJ Stock Holding History

Auxier Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,525
Closed -$2.53M – 159
2016
Q4 		$2.53M Buy
31,525
+151
+0.5% +$12K 0.55% 58
2016
Q3 		$2.5M Sell
31,374
-599
-2% -$48.4K 0.56% 59
2016
Q2 		$2.49M Buy
31,973
+1
+0% +$71 0.57% 56
2016
Q1 		$1.76M Buy
31,972
+9,953
+45% +$542K 0.42% 63
2015
Q4 		$1.36M Buy
+22,019
New +$1.39M 0.31% 78

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Auxier Asset Management's STJ Position: Q1 2017 in Review

Auxier Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 31,525 shares — an estimated $2.53M sold.

Auxier Asset Management first reported a position in STJ in Q4 2015 and held it in 5 quarters. The position peaked at $2.53M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Auxier Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Auxier Asset Management sold 31,525 St Jude Medical shares in Q1 2017, an estimated $2.53M.
  • Auxier Asset Management first reported a position in St Jude Medical in Q4 2015 and held it in 5 quarters.
  • Auxier Asset Management's St Jude Medical position peaked at $2.53M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Auxier Asset Management's 13F filing for Q1 2017, filed 12 May 2017.